Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1984 2
1985 2
1987 2
1988 1
1989 1
1990 1
1996 2
1997 1
1998 3
1999 2
2001 1
2003 1
2004 1
2007 3
2008 7
2009 8
2010 8
2011 4
2012 16
2013 16
2014 18
2015 20
2016 19
2017 15
2018 20
2019 17
2020 14
2021 12
2022 15
2023 14
2024 12
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
International Multiple Sclerosis Genetics Consortium (IMSGC); Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC); Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofont… See abstract for full author list ➔ International Multiple Sclerosis Genetics Consortium (IMSGC), et al. Among authors: robertson np. Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29. Nat Genet. 2013. PMID: 24076602 Free PMC article.
Advances in the treatment of the muscular dystrophies.
Wood C, Robertson NP. Wood C, et al. Among authors: robertson np. J Neurol. 2024 Jul;271(7):4724-4726. doi: 10.1007/s00415-024-12493-z. Epub 2024 Jun 20. J Neurol. 2024. PMID: 38900296 No abstract available.
Acute stroke management.
Tallantyre EC, Robertson NP. Tallantyre EC, et al. Among authors: robertson np. J Neurol. 2015 Jan;262(1):239-42. doi: 10.1007/s00415-014-7607-1. J Neurol. 2015. PMID: 25504307 No abstract available.
HIV-associated neurocognitive disorders.
Harding KE, Robertson NP. Harding KE, et al. Among authors: robertson np. J Neurol. 2015 Jun;262(6):1596-8. doi: 10.1007/s00415-015-7783-7. J Neurol. 2015. PMID: 26001912 No abstract available.
Secondary antibody deficiency in neurology.
Tallantyre EC, Robertson NP, Jolles S. Tallantyre EC, et al. Among authors: robertson np. Curr Opin Allergy Clin Immunol. 2018 Dec;18(6):481-488. doi: 10.1097/ACI.0000000000000485. Curr Opin Allergy Clin Immunol. 2018. PMID: 30299398 Review.
Real-world persistence of multiple sclerosis disease-modifying therapies.
Tallantyre EC, Dobson R, Froud JLJ, St John FA, Anderson VM, Arun T, Buckley L, Evangelou N, Ford HL, Galea I, George S, Gray OM, Hibbert AM, Hu M, Hughes SE, Ingram G, Kalra S, Lim CE, Mathews JTM, McDonnell GV, Mescall N, Norris S, Ramsay SJ, Rice CM, Russell MJ, Shawe-Taylor MJ, Williams TE, Harding KE, Robertson NP. Tallantyre EC, et al. Among authors: robertson np. Eur J Neurol. 2024 Jul;31(7):e16289. doi: 10.1111/ene.16289. Epub 2024 Apr 3. Eur J Neurol. 2024. PMID: 38567516 Free PMC article.
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis.
Roos I, Sharmin S, Malpas C, Ozakbas S, Lechner-Scott J, Hodgkinson S, Alroughani R, Eichau Madueño S, Boz C, van der Walt A, Butzkueven H, Buzzard K, Skibina O, Foschi M, Grand'Maison F, John N, Grammond P, Terzi M, Prévost J, Barnett M, Laureys G, Van Hijfte L, Luis Sanchez-Menoyo J, Blanco Y, Oh J, McCombe P, Ramo Tello C, Soysal A, Prat A, Duquette P, Yamout BI, Khoury S, van Pesch V, Macdonell R, José Sá M, Slee M, Kuhle J, Maimone D, Spitaleri D, Willekens B, Asmi AA, Tallantyre E, Robertson NP, Coles A, L Brown JW, Kalincik T. Roos I, et al. Among authors: robertson np. Mult Scler. 2024 Aug;30(9):1163-1175. doi: 10.1177/13524585241267211. Epub 2024 Aug 1. Mult Scler. 2024. PMID: 39087208
Advances in Tourette's syndrome.
Robertson NP. Robertson NP. J Neurol. 2023 Mar;270(3):1808-1810. doi: 10.1007/s00415-023-11588-3. Epub 2023 Feb 17. J Neurol. 2023. PMID: 36800018 Free PMC article. No abstract available.
Clinical patterns in CADASIL.
Gailani G, Robertson NP. Gailani G, et al. Among authors: robertson np. J Neurol. 2022 Aug;269(8):4575-4577. doi: 10.1007/s00415-022-11261-1. Epub 2022 Jul 14. J Neurol. 2022. PMID: 35833984 Free PMC article. No abstract available.
Alemtuzumab for Multiple Sclerosis.
Willis MD, Robertson NP. Willis MD, et al. Among authors: robertson np. Curr Neurol Neurosci Rep. 2016 Sep;16(9):84. doi: 10.1007/s11910-016-0685-y. Curr Neurol Neurosci Rep. 2016. PMID: 27485945 Free PMC article. Review.
236 results